Ronald Schilderink

729 total citations
13 papers, 499 citations indexed

About

Ronald Schilderink is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Ronald Schilderink has authored 13 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmaceutical Science and 4 papers in Immunology. Recurrent topics in Ronald Schilderink's work include Drug Solubulity and Delivery Systems (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (3 papers). Ronald Schilderink is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (3 papers). Ronald Schilderink collaborates with scholars based in Netherlands, United Kingdom and Germany. Ronald Schilderink's co-authors include Wouter J. de Jonge, Caroline Verseijden, Mans Minekus, R. Havenaar, Miriam Verwei, Evelijn Zeijdner, Gijs R. van den Brink, Vanesa Muncan, Jurgen Seppen and Tim T. Lambers and has published in prestigious journals such as Gastroenterology, Frontiers in Immunology and International Journal of Pharmaceutics.

In The Last Decade

Ronald Schilderink

12 papers receiving 490 citations

Peers

Ronald Schilderink

IMMUN

PHYSI

Florian Thieme Germany

Azusa Takahashi Japan

J G Hastewell United Kingdom

Sushma Verma India

Kanit Atisook Thailand

C. Galabert France

Malek Zihlif Jordan

Mitra Abbasifard Iran

Carmen Zhang United States

Florian Thieme Germany

Ronald Schilderink

404 ×1.5

30 ×0.3

91 ×1.2

IMMUN

67 ×0.9

PHYSI

36 ×0.6

Citations per year, relative to Ronald Schilderink Ronald Schilderink (= 1×) peers Florian Thieme

Countries citing papers authored by Ronald Schilderink

Since Specialization

Citations

This map shows the geographic impact of Ronald Schilderink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Schilderink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Schilderink more than expected).

Fields of papers citing papers by Ronald Schilderink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Schilderink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Schilderink. The network helps show where Ronald Schilderink may publish in the future.

Co-authorship network of co-authors of Ronald Schilderink

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Schilderink. A scholar is included among the top collaborators of Ronald Schilderink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Schilderink. Ronald Schilderink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bellmann, Susann, Mans Minekus, Ronald Schilderink, et al.. (2021). In Vitro Simulation of the Environment in the Upper Gastrointestinal Lumen After Drug Administration in the Fed State Using the TIM-1 System and Comparison With Luminal Data in Adults. Journal of Pharmaceutical Sciences. 111(1). 197–205. 6 indexed citations

Ghiboub, Mohammed, Jing Zhao, Andrew Y. F. Li Yim, et al.. (2020). HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages. Frontiers in Immunology. 11. 550769–550769. 50 indexed citations

Ojala, K., Ronald Schilderink, Pirjo Nykänen, et al.. (2020). Predicting the effect of prandial stage and particle size on absorption of ODM-204. European Journal of Pharmaceutics and Biopharmaceutics. 156. 75–83. 7 indexed citations

Schilderink, Ronald, et al.. (2020). On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197. European Journal of Pharmaceutics and Biopharmaceutics. 149. 154–162. 17 indexed citations

Αbeele, Jens Van Den, Ronald Schilderink, Felix Schneider, et al.. (2017). Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools. Molecular Pharmaceutics. 14(12). 4220–4232. 29 indexed citations

Schilderink, Ronald, Matthew Bell, Inmaculada Rioja, et al.. (2016). BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells. Molecular Immunology. 79. 66–76. 23 indexed citations

Schilderink, Ronald, Caroline Verseijden, Jurgen Seppen, et al.. (2016). The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC. American Journal of Physiology-Gastrointestinal and Liver Physiology. 310(11). G1138–G1146. 129 indexed citations

Verwei, Miriam, Mans Minekus, Evelijn Zeijdner, Ronald Schilderink, & R. Havenaar. (2015). Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms. International Journal of Pharmaceutics. 498(1-2). 178–186. 90 indexed citations

Heinsbroek, Sigrid E.M., Mario Leonardo Squadrito, Ronald Schilderink, et al.. (2015). miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation. Mucosal Immunology. 9(4). 960–973. 30 indexed citations

10.

Schilderink, Ronald, Caroline Verseijden, & Wouter J. de Jonge. (2013). Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis. Frontiers in Immunology. 4. 226–226. 93 indexed citations

11.

Dijk, Remco van, Christel Rivière, Ronald Schilderink, et al.. (2013). Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in vitro and enhances adeno-associated virus liver directed gene therapy in vivo. Human Gene Therapy Methods. 3405000732–3405000732.

12.

Dijk, Remco van, Christel Rivière, Ronald Schilderink, et al.. (2013). Polyinosinic Acid Blocks Adeno-Associated Virus Macrophage Endocytosis In Vitro and Enhances Adeno-Associated Virus Liver-Directed Gene Therapy In Vivo. Human Gene Therapy. 24(9). 807–813. 24 indexed citations

13.

Schilderink, Ronald, et al.. (2012). Mo2068 Histone Deacetylase Dependent Regulation of Cytokine Secretion in Murine and Human Macrophages. Gastroenterology. 142(5). S–732. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact